Epoprostenol

CHEMBL1139 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

352.5 g/mol

LogP

2.9

Phase

4

This potent medication dilates blood vessels in the lungs and prevents blood clots from forming, helping to reduce the high blood pressure in the pulmonary circulation. It is used to treat severe pulmonary arterial hypertension.

Peso Molecular

352,5000 g/mol

LogP

2,90

TPSA

87,00 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Cardiovascular Disease Chronic Obstructive Pulmonary Disease Migraine Stroke Deep Vein Thrombosis / Pulmonary Embolism Type 2 Diabetes Hypertension Breast Cancer Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)O[C@H]2C[C@H]1O

InChI

InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1

Molecular Formula

C20H32O5

HBD / HBA

3 / 5

Ligações Rotacionáveis

10

Átomos Pesados

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This potent medication dilates blood vessels in the lungs and prevents blood clots from forming, helping to reduce the high blood pressure in the pulmonary circulation. It is used to treat severe pulmonary arterial hypertension.

Yes, Epoprostenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1139. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5282411. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Epoprostenol no PillFYI

Estrutura

Dados Rápidos

Fórmula: C20H32O5
Sinônimos: 2

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.